Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy
Author:
Affiliation:
1. Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
Funder
Institute of Radiation Medicine
Chinese Academy of Medical Sciences & Peking Union Medical College
CAMS
Publisher
Informa UK Limited
Subject
Pharmaceutical Science
Link
https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2018.1440400
Reference92 articles.
1. Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
2. OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
3. Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
4. Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity
5. Aberrant expression of CD227 is correlated with tumor characteristics and invasiveness of breast carcinoma
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3;Cell Reports Medicine;2024-01
2. VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy;Cancer Cell International;2023-11-07
3. Listeria monocytogenes: a promising vector for tumor immunotherapy;Frontiers in Immunology;2023-10-06
4. Immune interactions in pembrolizumab (PD-1 inhibitor) cancer therapy and cardiovascular complications;American Journal of Physiology-Heart and Circulatory Physiology;2023-10-01
5. Breaking Tumor Immunosuppressive Network by Regulating Multiple Nodes with Triadic Drug Delivery Nanoparticles;ACS Nano;2023-09-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3